Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry

Ann Rheum Dis. 2010 Feb;69(2):471-2. doi: 10.1136/ard.2008.107102.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Middle Aged
  • Off-Label Use
  • Rituximab
  • Spondylarthropathies / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Rituximab